The Peripheral Immune Traits Changed in Patients with Multiple System Atrophy

A growing body of evidence suggests immune involvement in the pathology of multiple system atrophy (MSA). Research on detailed peripheral immune indices, however, is relatively sparse, and is one of the intriguing aspects of MSA yet to be elucidated. A total of 26 MSA patients and 56 age-and sex-matched healthy controls (HC) were enrolled in the current case-control study to delineate the peripheral immune traits of MSA patients. The ratio of CD4+/CD8+ T cells, natural killer cells, CD28 expression on both CD4+ T cells and CD8+ T cells increased in MSA patients compared to HC, but CD8+ T cells and active marker (HLA-DR) expression on total T cells decreased (p < 0.05). This study sheds light on the dysregulation of cellular immunity in MSA, pointing to future mechanistic research.

[1]  Juan Huang,et al.  Monocytohigh-density lipoprotein ratio has a high predictive value for the diagnosis of multiple system atrophy and the differentiation from Parkinson’s disease , 2022, Frontiers in Aging Neuroscience.

[2]  Kelly B. Menees,et al.  New Insights and Implications of Natural Killer Cells in Parkinson’s Disease , 2022, Journal of Parkinson's disease.

[3]  K. Jellinger.  Heterogeneity of Multiple System Atrophy: An Update , 2022, Biomedicines.

[4]  Natalia Madetko,et al.  Platelet-to-lymphocyte ratio and neutrophil-tolymphocyte ratio may reflect differences in PD and MSA-P neuroinflammation patterns. , 2022, Neurologia i neurochirurgia polska.

[5]  S. A. van de Pavert,et al.  Innate Lymphoid Cells in the Central Nervous System , 2022, Frontiers in Immunology.

[6]  H. Shang,et al.  High neutrophil-to-lymphocyte ratio predicts short survival in multiple system atrophy , 2022, npj Parkinson's Disease.

[7]  J. Pu,et al.  Specific immune status in Parkinson’s disease at different ages of onset , 2022, NPJ Parkinson's disease.

[8]  H. Shang,et al.  Neutrophil-to-lymphocyte ratio in sporadic amyotrophic lateral sclerosis , 2021, Neural regeneration research.

[9]  Chun-Feng Liu,et al.  Identifying the Hub Gene and Immune Infiltration of Parkinson's Disease Using Bioinformatical Methods , 2022, SSRN Electronic Journal.

[10]  Yuhu Zhang,et al.  Significant Difference of Immune Cell Fractions and Their Correlations With Differential Expression Genes in Parkinson’s Disease , 2021, Frontiers in Aging Neuroscience.

[11]  Xiaoguang Luo,et al.  High Inflammatory Tendency Induced by Malignant Stimulation Through Imbalance of CD28 and CTLA-4/PD-1 Contributes to Dopamine Neuron Injury , 2021, Journal of inflammation research.

[12]  Jing Yang,et al.  Evidence for Peripheral Immune Activation in Parkinson’s Disease , 2021, Frontiers in Aging Neuroscience.

[13]  D. Standaert,et al.  CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease , 2021, Brain : a journal of neurology.

[14]  M. Romero-Ramos,et al.  Periphery and brain, innate and adaptive immunity in Parkinson’s disease , 2021, Acta Neuropathologica.

[15]  J. Kira,et al.  Early decrease in intermediate monocytes in peripheral blood is characteristic of multiple system atrophy-cerebellar type , 2020, Journal of Neuroimmunology.

[16]  H. Shang,et al.  Elevated Percentage of CD3+ T-Cells and CD4+/CD8+ Ratios in Multiple System Atrophy Patients , 2020, Frontiers in Neurology.

[17]  H. Hou,et al.  The laboratory tests and host immunity of COVID-19 patients with different severity of illness. , 2020, JCI insight.

[18]  B. Pakkenberg,et al.  Epigenetic modulation of AREL1 and increased HLA expression in brains of multiple system atrophy patients , 2020, Acta Neuropathologica Communications.

[19]  V. Labrie,et al.  T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils , 2020, bioRxiv.

[20]  D. Standaert,et al.  T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease , 2020, Acta Neuropathologica.

[21]  Neslihan Eskut,et al.  The neutrophil-to-lymphocyte ratio as a marker of peripheral inflammation in progressive supranuclear palsy: a retrospective study , 2020, Neurological Sciences.

[22]  Zhenxiang Zhao,et al.  Abnormal subpopulations of peripheral blood lymphocytes are involved in Parkinson's disease. , 2019, Annals of translational medicine.

[23]  E. Tolosa,et al.  Cerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry study. , 2019, Parkinsonism & Related Disorders.

[24]  Han-Joon Kim,et al.  Does peripheral inflammation contribute to multiple system atrophy? , 2019, Parkinsonism & related disorders.

[25]  Weilei Hu,et al.  Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities , 2019, Front. Immunol..

[26]  D. Finlay,et al.  Immunometabolism and natural killer cell responses , 2019, Nature Reviews Immunology.

[27]  M. Azuma.  Co-signal Molecules in T-Cell Activation : Historical Overview and Perspective. , 2019, Advances in experimental medicine and biology.

[28]  S. Friis,et al.  Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes , 2018, Journal of Neuroinflammation.

[29]  N. Sawamoto,et al.  NLRP3 Inflammasome-Related Proteins Are Upregulated in the Putamen of Patients With Multiple System Atrophy , 2018, Journal of neuropathology and experimental neurology.

[30]  Y. Surova,et al.  Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders , 2018, Alzheimer's & Dementia.

[31]  K. Jellinger.  Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy , 2017, Journal of Alzheimer's disease : JAD.

[32]  B. Pakkenberg,et al.  Cytokine profiling in the prefrontal cortex of Parkinson's Disease and Multiple System Atrophy patients , 2017, Neurobiology of Disease.

[33]  Yousheng Xiao,et al.  Peripheral Lymphocyte Subsets as a Marker of Parkinson’s Disease in a Chinese Population , 2017, Neuroscience Bulletin.

[34]  Pengfei Wang,et al.  The correlation of lymphocyte subsets, natural killer cell, and Parkinson’s disease: a meta-analysis , 2017, Neurological Sciences.

[35]  A. Hiwatashi,et al.  Early strong intrathecal inflammation in cerebellar type multiple system atrophy by cerebrospinal fluid cytokine/chemokine profiles: a case control study , 2017, Journal of Neuroinflammation.

[36]  B. Engelhardt,et al.  The movers and shapers in immune privilege of the CNS , 2017, Nature Immunology.

[37]  Kan Li,et al.  Serum Lymphocyte-Associated Cytokine Concentrations Change More Rapidly over Time in Multiple System Atrophy Compared to Parkinson Disease , 2017, Neuroimmunomodulation.

[38]  Jonathan H. Esensten,et al.  CD28 Costimulation: From Mechanism to Therapy. , 2016, Immunity.

[39]  Tianrong Li,et al.  Monte Carlo cross-validation analysis screens pathway cross-talk associated with Parkinson’s disease , 2016, Neurological Sciences.

[40]  S. Hendrix,et al.  Immunotherapy of Parkinson’s Disease , 2016 .

[41]  G. Guillemin,et al.  Neuroinflammation in Multiple System Atrophy: Response to and Cause of α-Synuclein Aggregation , 2015, Front. Cell. Neurosci..

[42]  G. Bernardini,et al.  NK cells and interferons. , 2015, Cytokine & growth factor reviews.

[43]  F. Hentges,et al.  NK Cells in Central Nervous System Disorders , 2013, The Journal of Immunology.

[44]  Y. Surova,et al.  Proinflammatory Cytokines Are Elevated in Serum of Patients with Multiple System Atrophy , 2013, PloS one.

[45]  Pablo Villoslada,et al.  Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity , 2013, BMC Systems Biology.

[46]  G. Halliday,et al.  Reduced T helper and B lymphocytes in Parkinson's disease , 2012, Journal of Neuroimmunology.

[47]  N. Kuriyama,et al.  Effects of peripheral lymphocyte subpopulations and the clinical correlation with Parkinson's disease , 2012, Geriatrics & gerontology international.

[48]  P. Fagone,et al.  Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor. , 2011, Cytokine.

[49]  G. Wenning,et al.  Multiple system atrophy: an update , 2009, The Lancet Neurology.

[50]  P Sandroni,et al.  Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.

[51]  M. Nakashima,et al.  Natural killer cells of Parkinson's disease patients are set up for activation: a possible role for innate immunity in the pathogenesis of this disease. , 2008, Parkinsonism & related disorders.

[52]  Christiane,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2004, Journal international de bioethique = International journal of bioethics.

[53]  S. Ambrosio,et al.  Lymphocyte populations in Parkinson’s disease and in rat models of parkinsonism , 2001, Journal of Neuroimmunology.

[54]  J. Bluestone,et al.  CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.

[55]  G. Trinchieri,et al.  Human natural killer cells. , 1979, Transplantation proceedings.

[56]  Yingjie Jia,et al.  Reference range of naïve T and T memory lymphocyte subsets in peripheral blood of healthy adult , 2022 .